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Mesoporous Silica Nanoparticles (MSN) are used in an increasing number of applications in nanomedicine. Their 
synthesis and external/internal functionalization have been extensively studied as well as their biological 
properties. Nevertheless, the conventional drug loading processes of MSN (such as impregnation), do not enable 
sufficient efficiency and are difficult to consider on an industrial scale. To overcome these limitations, we im­
plemented an innovative CCHipray-drying process, using a nano spray-dryer, to Joad MSN with ibuprofen mo­
lecules. ln this contribution, complementary techniques were used to perform a multi«ale characterization of 
the loaded particles. Spray-dried powders have been analysed from aggregates size and morphology to pore 
loading and ibuprofen conformation. This study demonstrates that ibuprofen/silica weight ratio in the initial 
suspension strongly affects the location (into mesopores or external) and the conformation (crystallized, 
amorphous or liquid-like) of ibuprofen. The quantification of each phase bas allowed calculating precise loading 
rates and demonstrate tunable pore filling. 
1. Introduction
During the last decade, Mesoporous Silica Nanoparticles (MSN) 
have been increasingly studied for various therapeutic and diagnostic 
applications, and in particular for cancer treatments (1 4).As other 
nanosystems like liposomes or dendrimers, MSN act as nanocarriers, 
delivering therapeutic (bio)molecules to a targeted location (cancer 
cell, tumor), preventing or restricting severe side effects. MSN are of 
huge interest because their numerous and complementary ways of 
elaboration allow finely tuning their properties. Among them, four 
properties strongly impact their efficiency (3,5): 
Nanoparticles size and morphology/aspect ratio as they influence 
localization and intemalization of MSN in the body (1,6). 
Pore diameter, morphology (hollow sphere, interconnection) and 
organization (hexagona� radial, worm like) that are predominant 
for drug loading and release (diffusion, dissolution) (7,8). 
Extemal and internai functionalization (9) The extemal (bio)func 
tionalization could have two main purposes: (a) Selective targeting 
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for localized therapy using functions able to selectively interact with 
specific overexpressed receptors, (b) smart control of drug delivery 
thanks to gatekeepers that are (bio)organic stimuli responsive en 
tities blocking or opening pores (3,10,11). The internai functiona 
lization enables a better interaction between the drug molecules and 
the nanocarriers and could have an influence on the drug release 
(12 14), MSN loading processes/mechanisms (especially with
hydrophobie drugs) and consequently the optimization of loading 
rate considering the available specific surface area and/or pore 
volume. 
While the three first properties have been extensively described in 
the literature, the last one have been much Jess studied. Severa) pro 
cesses may be used for drug loading. The easiest technique is commonly 
called impregnation. lt consists of putting in extended contact MSN and 
a saturated drug solution. The sol vent (usually organic) is then removed 
by evaporation (heating), centrifugation or filtration but the powder 
recovery yield is not optimized (15). This method is driven by the 
thermodynamic equilibrium between solvated ibuprofen molecules and 
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Mesoporous Silica Nanoparticles (MSN) have been synthesized by
the sol gel technique in a basic media, with TEOS as silica precursor and
CTAB as cationic surfactant [16,37,38]. Brieﬂy, 1.0 g of CTAB and 7mL
of NaOH (2mol L−1), were added in 960mL of deionized water inside a
double jacketed reactor (1 L, four waﬄes) at 80 °C. The solution was
mixed by mechanical stirring at 175 rpm for 30min with an A310 axial
ﬂow impeller (Lightin). The stirring rate was next increased to 550 rpm
and 10mL of TEOS were added in the reactor with a peristaltic pump
(Masterﬂex L/S) at 120mL h−1. After 2 h, the solution was ﬁltered
(Sartorius 391 ﬁlter, particle retention=2 3 μmm) with a Büchner and
the resulting ﬁlter cake was washed with 3x500 mL of deionized water
and 3x100 mL of technical ethanol 96%. After freezing (12 h, −20 °C)
and lyophilisation (24 h,−55 °C, 1mbar) with a Alpha 1 2 LyoDisplay
freeze dryer (Christ), the resulting powder has been calcined overnight
in a tubular furnace at 600 °C under air ﬂow in order to remove CTAB.
Several batches of MSN were synthesized in the same conditions. The
resulting powders were controlled thanks to DLS, SAXS and N2 ad
sorption. Then they were mixed in order to have a suﬃcient amount of
powder with uniform properties to be used during the spray drying
experiments.
2.3. Drug loading by co spray drying
The co spray drying process was used to load the ibuprofen into
silica mesopores with the Nano Spray Dryer B 90 from Büchi
Labortechnik AG. Fig. 1 illustrates the ﬂowsheet of this apparatus [39].
Several experiments were performed varying the Ibuprofen/Silica
mass ratio in the stock suspension (Fig. 1 ①) in order to analyse the
eﬀect of this key parameter on the MSN loading. The silica concentra
tion stayed constant (5 g L−1). The volume of ethanol was calculated
depending on the amount of silica, whereas the ibuprofen concentration
was the variable parameter (from 1 to 20 g L−1, see Table 1 and Fig. 2
a,b,c). This initial suspension was sonicated before the co spray drying
experiment during 5min at 350W (FB705 Fisherbrand Ultrasonic Pro
cessor), and stirred during all the process in order to facilitate the
dissolution of ibuprofen and the dispersion of MSN. After the pumping
of the suspension, droplets are generated with a piezoelectrically driven
vibrating mesh (Fig. 1 ③); these droplets are formed with a narrow size
distribution controlled by the membrane vibration (spray mesh size of
7 μm) [31,32]. A ﬂow of hot nitrogen gas (70 °C, 35 mbar, around
95 Lmin−1) dries the droplets inside the drying chamber while eva
porating the solvent (Fig. 1 ② and ④) and generates dried powder
composed of particles agglomerates. Then, the powder is collected with
an electrostatic collector (Fig. 1 ⑤) instead of a cyclone technology as in
conventional spray dryers. A stainless steel cylinder allows to collect
the particles because of a high voltage application between this elec
trode and a star shaped counter electrode (cathode); spray dried
powder is then charged and electrostatically deposited on the inner wall
of the cylinder electrode. This mechanism is independent of particle
mass (unlike for the cyclone technology) and is based on particles
electrostatic charging.
The short conﬁguration (height: 110 cm) of the drying chamber has
been used. Due to the use of a fully organic solvent (ethanol), the spray
dryer was combined with diﬀerent Büchi accessories allowing to inert
the system (Inert Loop B 295), avoid the presence of water
(Dehumidiﬁer B 296) and recycle the drying gas used with the Büchi
Aspirator. After the spray drying, the powder was removed from the
cylinder electrode through a particle scrapper.
2.4. Characterization
An important part of this work has been focused on the character
ization of powders generated by spray drying in order to have a better
understanding of the inﬂuence of the mass ratio of ibuprofen over silica
(noted R= ibu:Si thereafter) on the properties of the particles.
Dynamic Light Scattering (DLS): Hydrodynamic diameters of the MSN
in suspension were obtained with a ZetaSizer Nano ZS (Malvern
those physisorbed into mesoporous silica and the associated diﬀusion 
[16,17] Melt quenching is based on the mix of MSN and drug when 
heated in order to melt the latter, which helps the active substance to be 
loaded in the material; then, a quench is realized with liquid nitrogen. 
The main limiting parameter is the loading eﬃciency and its localiza 
tion due to the viscosity of the molten drug [18]. A third alternative is 
the manual mixing where two diﬀerent solids (silica matrix and drug) 
are put in a mortar and mixed manually with a pestle [19] However, 
these diﬀerent techniques (manual mixing, melt quenching) are hard to 
optimize [15,19] and result in poor loading rates. Moreover these 
processes cannot be easily transferred on an industrial scale. Complete 
studies, considering several parameters (mesoporous structure, func 
tionalization) [20] and including ﬁne characterizations (NMR, SAXS, 
TEM) [19,21 24,26] have been carried out on mesoporous silica loaded 
thanks to previous processes. These articles were mostly focused on 
mesoporous silica under powder form composed of micron scale grains 
with larger diﬀusion pathway for molecules into the mesoporous net 
work, comparing to nanoparticles.
Compared to the above mentioned drug loading processes, the co 
spray drying process seems to have a high potential. Currently used in 
the industry to produce a dry powder from a solution or a suspension, 
the spray drying allows to load an active substance in a matrix, with a 
ﬁnal product in a stabilized form [27,28] It has some beneﬁts like the 
process duration and the recovery yield of the powder [19]. The 
greatest advantage of the spray drier is its ability, in one step, to load 
the drug and separate the loaded product from the solvent by drying it. 
Nano spray dryers allow highly eﬃcient nanoparticles recovery thanks 
to electrostatic collection system [29 32]. One article [19] has been 
published on the use of a mini spray dryer to load micronic mesoporous 
silica, but to the best of our knowledge, there is no description related 
to mesoporous silica nanoparticles combined with the use of a nano 
spray dryer and especially with full and multi tool characterization.
In this context, the aim of the present work consists in developing 
the co spray drying process with nano spray dryer for the eﬀective 
loading of a model molecule into MSN. Ibuprofen has been chosen due 
to its physico chemical properties (slightly water soluble) and its mo 
lecular size. Moreover, a good knowledge of its properties is made 
possible thanks to an abundant literature [33 36] The impact of MSN/
ibuprofen ratio in the initial suspension (before spray drying) on mor 
phological and structural properties of resulting powders will be espe 
cially studied thanks to complementary techniques such as MEB, SAXS, 
solid state NMR, N2 adsorption, MET. Consequently, this paper aspires 
to: i) highlight the mechanisms leading to the multi scale organization 
of MSN loaded with ibuprofen (from micronic agglomerates size to the 
molecular conformation), ii) determine the correlation between the 
diﬀerent ibuprofen states and their location (internal/external) and 
quantify the proportion of each state to calculate precise pore loading 
rates.
2. Experimental
2.1. Materials
Tetraethyl orthosilicate solution (TEOS, ≥99%), 
Hexadecyltrimethylammonium bromide powder (CTAB, ≥98%) and 
sodium hydroxide pellets (NaOH, ≥98%) were purchased from Sigma 
Aldrich. Ibuprofen 50 powder was purchased from BASF (particle size 
around 50 μm). Technical ethanol (96%), used for ﬁltrations, was 
purchased from Acros Organics and absolute ethanol (≥99.8%), used 
for loading experiments, was purchased from Fisher Chemical. 
Deionized water (18.2 MΩ cm−1) was used for the particle synthesis 
and the ﬁltrations.
2.2. Nanoparticle synthesis
Instruments Ltd). This equipment uses a laser (He Ne at λ=633 nm,
under voltage of 3mV) and the detector is located at 173° to analyse the
scattered intensity ﬂuctuations. 10 mg of MSN were dispersed inside
20mL of water with the ultrasonic processor [40] (5min, 350W) prior
to the measurement performed at a temperature of 25 °C.
N2 Adsorption: Nitrogen adsorption/desorption isotherms were
performed to characterize the textural properties of the MSN and the
spray dried samples with a Tristar II (Micromeritics). The samples were
vacuum outgassed at ambient temperature for 24 h to remove physi
cally adsorbed water molecules from the pores. Pore size distributions
of the MSN were determined from the desorption isotherm with the
Barret Joyner Hallenda (BJH) method [41] The speciﬁc surface areas
and pore volumes were determined from the linear portion of the
Brunauer Emmet Teller (BET) plots [42].
Small Angle X Rays Scattering (SAXS): The SAXS analyses were per
formed on XEUSS 2.0 (Xenocs Company) composed of X ray micro
source delivering at 8 keV a spot sized beam equal to 0.5 mm with an
intensity close to 30*106 photons.s−1. The samples were placed on
sample loader dedicated to powders with 387.5mm of distance from
the detector, providing a range of scattering vector starting from
0.02 Å−1 to 1.6 Å−1. The samples were exposed during 300 s under
vacuum and the scattered beam was collected on the 1M Pilatus de
tector (1 million counts/pixel). Data integration and reduction were
performed with the software FOXTROT.
Transmission Electron Microscopy (TEM): TEM images were taken by
a JEM 1400 electron microscope (JEOL). The conditions were as fol
lows: W ﬁlament, voltage of 120 kV, 3.8 Å of resolution. Scanning
Fig. 1. Flowsheet of the nano spray-drying process (adapted from 31).
Table 1
Spray-dried samples labelling depending on silica and ibuprofen mass in the initial suspension.
Samples (R= Ibu:Si) 0:100 20:80 25:75 30:70 35:65 40:60 45:55 50:50 80:20 100:0
msilica (mg) 400 629 501 478 426 401 376 375 200 0
mibuprofen (mg) 0 157 168 204 231 269 309 376 800 12010
Fig. 2. Schematic representation of initial suspensions with an increase of
ibuprofen quantity (a, b, c) and resulting powders obtained after spray-drying
(d, e, f) respectively.
highlight the spherical shape of particles. Their diameter varies from
100 to 250 nm (Appendix, A Figs. S2 a). DLS completes this informa
tion by giving a hydrodynamic particle diameter distribution (Appendix
A, Figs. S2 b) of MSN suspension. Even if the diameter is overestimated
(hydration layer) comparing to TEM, the distribution is monodisperse
and quite narrow (PDI< 0.3) with a modal diameter of 301 nm. Al
though the diameter of these particles seems to be high considering
biomedical applications, they have been chosen for their well organized
porosity. Indeed, smaller nanoparticles lead to disorganized or worm
like porosity for SBA or MCM derived silica [45]. Considering that the
aim of this article is the proof of concept of a possible eﬃcient loading,
well deﬁned porous network should be particularly adapted to char
acterize the state and organization of molecules into nanoparticles.
3.2. Morphology and composition of resulting agglomerates
After having performed the co spray drying process with diﬀerent
ibuprofen/silica ratios in the stock suspension, complementary techni
ques were used to characterize the hierarchical organization of re
sulting dried agglomerates. For the Ibu:Si ratio 100:0 (w/w) (i.e. pure
ibuprofen spray dried), the quantity used is much higher than other
ratios because the yield drastically dropped, due to the sticky behaviour
of the product (Table 1).
SEM gives information about the spatial localization of silica par
ticles and remaining solid ibuprofen (if any) into agglomerates. Fig. 5
shows high magniﬁcation of powder grains for diﬀerent ibuprofen/si
lica ratios (R). For spray dried pure silica (R=0:100), MSN are
spherically agglomerated and organized with a hollow sphere shape
(Fig. 5 a). This morphology is typical of fast solvent evaporation
(ethanol) in the drying chamber (Fig. 1 ④) during the spray drying
process [46 49]. When ibuprofen is added in the initial suspension and
the ibuprofen quantity is increased, the previous morphology is pre
served for the dried agglomerates formed at R=25:75 (Fig. 5 b) and
50:50 (Fig. 5 c), even so the central hole is less well deﬁned. Con
sidering low magniﬁcation pictures (Appendix A Fig. S3), the diameters
of agglomerates are between 1 and 7 μm with a broad size distribution
for these three conditions. These results imply that, for these ratios,
ibuprofen molecules are either entrapped inside mesopores or present
as small nanometric entities (undetectable with conventional SEM)
between silica nanoparticles. For higher ratio (R=80:20), agglomer
ates have irregular shapes (Fig. 5 d) with higher particle sizes between
10 and 40 μm. Interestingly they are mainly composed by a continuous
matrix on which silica particles are agglomerated. Due to the high
amount of ibuprofen compared to silica for this sample, we can assume
that this matrix is ibuprofen in a solid state. Globally, SEM pictures
suggest that the ibuprofen could get diﬀerent locations depending on
the Ibu:Si ratio.
For pure ibuprofen, the resulting grains are bigger with sizes of
several hundred microns with an important roughness (Fig. 5 e). These
ﬁnal grains may have a ﬂat shape due to the surface of the electrode
(ﬂattening of the grain due to the attractive force the electrode).
This could be enhanced by remaining ethanol in ibuprofen during
the collection, which make the powder stickier and more deformable.
This phenomenon may have been avoided for samples containing silica
particles, the later increasing the mechanical properties (stiﬀness) of
the resulting composite. Beyond location of ibuprofen, some selected X
ray diﬀraction patterns are presented on Fig. 6 (totality of patterns on
Appendix A Fig. S4) to check its physical state when dried. For free
ibuprofen sample (R= 0:100), a very broad halo centred around 26° is
observed. It is characteristic of the short range order (SiO4 tetrahedra)
of amorphous silica. This broad halo is still present when the ibuprofen
amount is increased regardless the sample, except for the 80:20 ratio.
Nevertheless, a series of additional sharp peaks are present from the
40:60 to the 100:0 ratios. These sharp peaks become more and more
intense as the ibuprofen percentage increases in the stock suspension.
These diﬀraction peaks were attributed to crystalline ibuprofen (main
Sample (R= Ibu:Si) Speciﬁc area
(m2.g 1)
Pore volume
(cm3.g 1)
dBJH (nm)
Initial MSN 806 0.754 3.0
0:100 787 0.657 2.9
20:80 477 0.357 2.2
25:75 266 0.196 1.9
30:70 132 0.115 2.0
35:65 23 0.045 –
40:60 23 0.043 –
50:50 25 0.044 –
100:0 0.43 0.006 –
Transmission Electron Microscopy (STEM) tests were performed using a 
JEOL cold FEG JEM ARM200F operated at 200 kV equipped with a 
probe Cs corrector reaching a spatial resolution of 0.078 nm. The de 
tector used is the High Angle Annular Dark Field (HAADF).
Scanning Electron Microscopy (SEM): SEM has been used to study the 
morphology of agglomerated particles. Electron micrographs were 
taken using the secondary electron mode using a FEI 450 Scanning 
Electron Microscope (Quanta SEM), with a voltage of 12.5 kV.
X Ray Diﬀraction (XRD): Powder X Ray Diﬀraction was performed 
using a Symphonix 1000 (INEL). The X ray source was a Co radiation 
(λ = 1.7889 Å) and measurement conditions were as follows: voltage of 
30 kV, current of 30 mA, room temperature, step size of 0.01°. Samples 
were manually ground before measurements to randomize the or 
ientation.
Thermogravimetric Analysis/Diﬀerential Thermal Analysis (TGA/DTA): 
TGA/DTA measurements were performed on a TGA DTA SETSYS 
Evolution (SETARAM Instrumentation) under air ﬂow. The samples 
were stabilized to 25 °C, then heated to 800 °C with a heating rate of 
5 °C/min. The acquisition system used was SETSYS Ev 1750. TGA has 
not been carried out for 80:20 sample due to the lack of spray dried 
collected powder.
Solid state Nuclear Magnetic Resonance (NMR): Solid state NMR ex 
periments were recorded on an Avance III HD 400 spectrometer 
(Bruker). Samples were packed into 4 mm zirconia rotors which were 
spun at 8 10 kHz at 298 K. 1H, 13C and 29Si MAS single pulse experi 
ments were performed with recycle delays of 3 s, 5 s and 60 s, respec 
tively. 13C CP/MAS and 29Si CP/MAS spectra were recorded with a 
recycle delay of 2 s and contact times of 2 m s and 3 m s respectively. 
13C MAS with Insensitive Nuclei Enhanced by Polarization Transfer 
(INEPT) were recorded with a recycle delay of 3s and interpulses delays 
synchronized with the spinning rate. A mixing time of 4 m s was used 
for 1H 1H NOESY experiment. All of the chemical shifts are relative to 
Tetramethylsilane.
3. Results and discussion
3.1. As synthesized silica nanoparticles
As synthesized mesoporous silica nanoparticles (MSN) have been 
analysed by means of several techniques. N2 adsorption/desorption 
isotherm (Appendix A Fig. S1) is type IV according to IUPAC [43] and 
nanoparticles exhibit a high BET [42] speciﬁc surface area of 
806 m2 g−1. Pore size distribution has been calculated with the BJH 
theory [41] and pores diameter is centred around 2.9 nm (Table 2). 
These values are similar to those obtained in the literature for this type 
of system [19,22]. SAXS measurements (Fig. 3 b) demonstrate a 2D 
hexagonal cylindrical network organization (P6mm) in honeycomb 
with the indexation of d100, d110 and d200 peaks (respectively q1, q2 and 
q3) and allows calculating the centre to centre distance, which is about 
4.1 nm, in agreement with the literature [44] TEM pictures conﬁrm the 
MCM 41 derived 2D hexagonal organization of pores (Fig. 4) and
Table 2
Surface properties obtained by nitrogen adsorption of MSN and spray-dried 
samples at diﬀerent ibuprofen/silica weight ratios (R).
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Fig. 4. STEM of spray-dried MSN (R = 0:100) in the axis of the pores (a) and 
perpendicular to the pores (b). 
peaks with following values of 28: 14.1, 19.3, 23.4, 25.9 and 32.2î 
(19). It corresponds to the most thermodynamically stable phase (a) 
with a P21/c symmetry. These results demonstrate that below the 40:60 
ratio, ibuprofen does not form crystal. It could be correlated with the 
previous hypothesis assuming that the molecules are located into me 
sopores for these ratios. It has been proved that the crystallisation of a 
molecule can occur in channels only if the channel diameter/molecular 
size ratio is more than 20.(50) In our case, the pore diameter is about 
3 nm (Table 2, Fig. 7) and the ibuprofen molecule is about 11.5 Â long 
(22). Thus, the size of mesopores avoids the formation of ibuprofen 
crystals inside them. Combining SEM pictures and XRD, we can assume 
that beyond the 40:60 ratio, nanocrystals of ibuprofen are formed out of 
porosity and tends to agglomerate. The hypothesis of the nanoscale of 
crystals is supported by the width of ibuprofen peaks resulting of small 
crystalline domains (Appendix A Fig. SS). The crystallite size has been 
calculated for pure spray dried ibuprofen thanks to the Scherrer equa 
tion applied to the (200) peak and is around 40 nm. The presenœ of 
;::, ,;; 
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Fig. 6. X•Ray diffraction patterns of raw ibuprofen and spray•dried samples 
with different ibuprofen/silica ratios. 
ibuprofen nanocrystals is consistent with the spray drying process. In 
deed, the ethanol solvent evaporation is very fast, promoting nucleation 
over growth. This trend may have been accentuated for samples con 
taining silica as each particle could enhance heterogeneous nucleation. 
Thermogravimetric Analysis (TGA) has been used to quantify the 
ibuprofen amount. TGA curves are presented in Fig. 8 a. For pure spray 
dried ibuprofen CR = 100:0) and considering the derivative of its curve, 
two main mass losses occur: the first one between 136 and 280 •c and 
the other one between 280 and 345 •c. Three main peaks could be 
observed on corresponding TGA results (Fig. 8 b): two endothermic 
peaks, respectively at 80 and 259 •c and an exothermic peak at 288 •c.
Acoording to the literature (51) these peaks can be respectively at 
tributed to the melting point, the boiling point and the degradation 
(oxidation) of ibuprofen, meaning that the first mass loss is due to 
ibuprofen evaporation and the second one to its deoomposition. With 
the same methodology, three zones have been determined for pure 
Silica / Ibaprolon ratio 
Fig. S. SEM pictures of spray•dried samples with different ibuprofen/silica ratios R: (a) 0:100, (b) 25:75, (c) 50:50, (d) 80:20, (e) 100:0. 
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Fig. 7. Pore size distributions obtained by nitrogen adsorption of MSN and 
spray-dried samples at different ibuprofen/silica ratios. lnsert: Focus on small 
pore diameters. 
silica nanoparticles. Below 150 •c, the first zone corresponds to the 
desorption of physisorbed water or ethanol (endothermic peak centred 
around 68 •c). Between 150 •c and 236 •c, a plateau is observed and 
above 236 •c, the weight loss is attributable to de hydroxylation, i.e.. the 
surface silanols condensation [52) For samples containing both ibu 
profen and silica, two domains separated by a clear break can be dis 
tinguished. This break occurs at 355, 344, 370 and 366 •c for respec 
tively 20:80, 25:75, 40:60 and 50:50 samples and is correlated to 
intense exothermic peaks suggesting that they could be linked to ibu 
profen degradation. It is interesting to note that endothermic peaks 
related to melting point of crystalline ibuprofen is only present for 
samples with initial Ibu:Si ratios above 40:60 (Fig. 8 b). These results 
can be correlated with those of XRD. Indeed, the melting temperature is 
only observed when crystals are detected. In any case, several points 
can be assumed: i) Below 150 •c the mass loss is only due to the removal 
of physisorbed remaining water or ethanol ii) Above this value the 
mass loss is related to ibuprofen removal (evaporation and/or de 
gradation). iii) At 800 •c the resulting material is de hydroxylated si 
lie a. iv) The amount of silanol groups at the surface of silica is the same 
whatever the samples. Indeed, ail particles are taken from the same lot 
(combination of different synthesis batches) and the conditions in the 
initial suspension and during the spray drying process are not severe 
enough to remove them (deprotonation, internai condensation) as de 
monstrated below by NMR. Considering these hypothesis, it is possible 
100 
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to calculate the weight percentage of each entity and especially of 
ibuprofen. Results are presented in Table 3. Residual water/ethanol 
amount in the dried samples decreases when ibuprofen increases. It 
seems consistent, as the number of ibuprofen molecules interacting 
with the silica matrix is increased (assuming that part of ibuprofen is 
inside the pores). Consequently, it reduces the probability of silanol 
interactions with small physisorbed molecules. Moreover, the ibu:silica 
weight ratio in spray dried powders reaches lower values comparing to 
those in the stock suspensions. This difference may be explained by the 
potential loss of isolated nano agglomerates of ibuprofen molecules 
carried away by the gas flow. 
3.3. Pore filling and ibuprof en confonnati.on 
The honeycomb network of the MSN seems to be unmodified by the 
presenœ of ibuprofen (TEM analysis, Appendix A Fig. S6). Although 
TEM pictures allow directly observing the porous network, they do not 
reveal any changes between initial MSN and silica particles co spray 
dried with ibuprofen. The difficulty in observing it could be explained 
by the combination of two factors: i) as ibuprofen is mainly constituted 
by carbon, the difference in electronic density between ibuprofen filled 
pores and silica network should not exhibit high contrast, ii) at the 
particle scale, the superposition of porous channels makes it difficult to 
distinguish the pore filling. 
On the contrary, SAXS reveals important changes when ibuprofen 
and silica are co spray dried. SAXS curves for MSN, for pure spray dried 
silica and for samples with different ratios are presented on Fig. 3 a. 
Until 0.1 Â -1, the domain (I) reveals that the negative slop of curves is
increased with the increase of ibuprofen ratio. MSN and R = 0:100 
(spray dried MSN) samples curves have slope close to 4-
3 
whereas that
of 80:20 is close to 4-4• As these slopes are related to the surface state
in the Porod domain, it could mean that the roughness of silica spheres 
is step by step reduced. lt is consistent with SEM and XRD analyses. 
Indeed, between 30:60 and 40:60 ratios, a layer of agglomerated ibu 
profen nanocrystals is progressively formed at the surface of nano 
particles after this molecule has filled pores. lt could explain the 
"smoothing" of particles surface due to the homogeneity of this ibu 
profen layer with low spatial variations of electronic density. The do 
main (II) (approximatively from 0.1 A-1 to 0.4 A-1) is the one that is
most usually studied in the field of structured mesoporous materials, as 
these peaks are due to the diffraction of x rays by the empty pores 
mesostructure due to high contrast of electronic density with silica 
matrix. First, these curves confirm that the silica structure is not 
modified during the co spray drying with or without ibuprofen. As 41, 
42 and 43 peaks have the same value for ail the samples and the 42/41 
and 43/41 values are close to each other (Table 4), we can guess that the 
140 
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Fig. 8. (a) Thermogravimetric analysis and (b) Differential thermal analysis of spray-dried samples with different ibupr ofen/silica ratios. Insert on (a): Focus on the 
0:100 cwve, insert on (b): Focus between 20 and 160 •c. 
P6mm structure remains the same with similar distance from centre to
centre of adjacent cylindrical pores (about 4.1 nm). However, the peak
intensity decreases as the ibuprofen amount increases. This phenom
enon could be explained by the decrease of the electronic density
contrast between silica and ibuprofen (mainly composed of carbon)
ﬁlling the pores. Thus an intensity decrease indicates the gradual ﬁlling
of pores. This kind of contrast decrease has already been described for
micron scale SBA 15 or MCM 41 particles ﬁlled by ibuprofen
[20,53,54] or naproxen [26] and characterized by SAXS or SAXRD. On
the contrary, the increase of contrast is associated to the presence in
pores of entities with higher electronic densities like iron oxide [55] or
metallic copper [56]. Finally, domain (III) crosschecks the information
obtained by XRD on the structural organisation of ibuprofen molecules.
The ﬁlling is still improved for 50:50 and 80:20 ratios, meaning that the
crystallisation of ibuprofen outside of particles revealed by XRD does
not occur because of a lack of free pore surface/volume for molecules.
To complete the understanding of pore ﬁlling, N2 adsorption mea
surements have been carried out (Table 2). BET calculations reveal two
tendencies of the speciﬁc surface area with an increase in the amount
ibuprofen: i) ﬁrst, it drastically and continuously decreases from 0:100
(787m2 g−1) to 35:65 (23m2 g−1). Within the same ratio domain, the
pore volume goes from 0.657 cm3 g−1 when there is no active substance
(R= 0:100) to 0.045 cm3 g−1, meaning that the speciﬁc area diminu
tion is related to mesopores ﬁlling. ii) Secondly, the speciﬁc surface
area remains the same for 35:65, 40:60 and 50:50 samples (around
25m2 g−1) as well as the pore volume (around 0.045 cm3 g−1). In order
to explain these results, two consecutive stages of pore ﬁlling need to be
considered. The ﬁrst one is due to ibuprofen physisorption during the
ﬁrst step, in the initial suspension. As there is a thermodynamical
equilibrium, the suspensions (regardless the concentration) are com
posed of adsorbed and free molecules, and could be described as a
Langmuir type isotherm [17,57]. Results on the 100:0 sample demon
strate that free molecules crystallize during the spray drying process
and the solvent evaporation. No crystalline phase is observed until
40:60 ratio (see XRD on Fig. 6). It could be explained by the second step
of loading: the solvent evaporation during the drying process leads to a
diﬀusion of the molecules from the solvent of the droplets to the pores
[58], modifying the previous organization of ibuprofen. Pore size dis
tribution has been calculated thanks to the BJH model (Fig. 7). Modal
pore size diameters (Table 2) slightly decreases when increasing the
amount of ibuprofen from 2.9 nm for pure spray dried silica to
approximatively 2 nm for samples for which no crystallisation is ob
served (until R=35:65). No modal diameter can be given beyond this
ratio, because no clear maximum appears in the mesoporous range.
These results need to be carefully considered as this is the limit of the
BJH theory [41], but we can reasonably suppose that the loading is ﬁrst
due to the formation of a layer inside mesopores for samples with low
initial ibuprofen concentration. For higher ibuprofen amount (from
R=40:60), the N2 molecules can no longer ﬁll the pores (reduction of
the speciﬁc surface area) because of an increase of volume loading of
ibuprofen (vs. previous surface loading). This low speciﬁc surface is
also induced by the crystalline ibuprofen matrix around the MSN
composed by previously free ibuprofen molecules that have not diﬀused
into the pores during the evaporation of ethanol. Similar results have
been obtained and explained by probing occluded void space inside
MCM 41 channels with 129Xe NMR [59] Considering this hypothesis,
the improvement of ﬁlled pores percentage observed by SAXS (decrease
of the q1 peak intensity between R=50:50 and R=80:20) for higher
ratios could also be explained even so the speciﬁc area remains the
same. Indeed, as the ratio of ibuprofen was higher in the initial sus
pension, and considering the equilibrium between free molecules and
adsorbed molecules, the amount of physisorbed molecules should be
higher. It could lead to an increased ﬁlling rate (Fig. 2 d,e,f).
Various NMR experiments have been achieved to gain information
on ibuprofen behaviour at the molecular scale. No clear diﬀerence for
samples from 20:80 to 100:0 could be observed by 29Si MAS and CP/
MAS NMR experiments (Appendix A Fig. 7). This conﬁrms that the
structure of mesoporous silica is not modiﬁed by the ibuprofen addi
tion. Notably the 29Si CP/MAS experiments, that enhance the Q2 (Si
(OSi)2(OH)2) and the Q3 (Si(OSi)3(OH)) silicon signals evidence that
there is no detectable dehydroxylation of the silica.
Carbon atoms have been probed using 13C MAS and CP/MAS NMR
experiments for several samples from 0:100 to 100:0 and for commer
cial crystalline ibuprofen and a solution of ibuprofen in ethanol (Fig. 9
and Fig. 10). As expected, for ibuprofen in solution very sharp peaks are
observed in 13C MAS experiment while no signal is detected in the 13C
CP/MAS experiment (1H 13C dipolar coupling average to zero due to
the fast tumbling motion in solution). On the contrary, for the well
crystallized commercial phase, 13C signal is easily seen with the CP/
MAS experiment while the detection is more diﬃcult with 13C MAS
experiment due to the very long 13C T1 relaxation times (e.g. T1 > 50 s
for aromatic and carbonyl carbons) (Fig. 9). With a relaxation delay of
Table 3
Weight percentages of diﬀerent entities in spray-dried powders (calculated thanks to TGA curves). Ibuprofen on silica weight ratios in the spray-dried powders and
the initial suspensions. For spray-dried samples, ratios have been calculated considering that silica weight is the summation of de-hydroxylated silica and surface
hydroxyl groups.
Sample Spray-dried powder Ibu: silica weight ratio
De-hydroxylated SiO2 OH groups Physisorbed entities
H2O/EtOH
Ibuprofen Spray-dried powder Initial suspension
wt% wt% wt% wt%
0:100 88.94 6.1 4.96 0.00 0.00 0.00
20:80 76.72 6.1 3.58 13.60 0.16 0.25
25:75 67.89 6.1 3.33 22.68 0.31 0.33
40:60 61.35 6.1 2.89 29.66 0.44 0.67
50:50 55.96 6.1 2.94 35.00 0.56 1.00
Table 4
Ratios of scattering vector values (SAXS) of diﬀraction peaks (q2/q1 and q3/q1) related to the mesoporous network and calculated centre-to-centre pores distances (a).
Theoretical values for hexagonal organization (P6mm) MSN 0:100 20:80 25:75 30:70 35:65 40:60 45:55 50:50 75:25 100:0
q2/q1 1.732 1.740 1.731 1.742 1.740 1.720 1.728 1.728 1.728 1.740 1.706 No silica
q3/q1 2.000 2.008 1.996 1.996 2.008 1.985 1.997 1.985 1.985 2.008 1.974
a (nm) – 4.115 4.187 4.180 4.220 4.204 4.237 4.245 4.245 4.220 4.270
5 s, the signal of mobile alkane groups that possess shorter T1 are much
more intense than the ones of aromatic and carbonyl groups. 13C MAS
spectra of spray dried ibuprofen (100:0 sample) are very similar to the
ones of the commercial crystalline sample. However, the 13C signals are
slightly broader (especially for the aromatic carbons 5 8, see Appendix
A Fig. S8) and the relative intensities of the aromatic signals in the 13C
MAS experiment are slightly higher (shorter T1 than in the crystalline
powder). This indicates that the spray dried ibuprofen is less crystal
lized than the commercial one. The 13C MAS spectra of samples 20:80,
25:75, 35:65 are very similar to the dissolved ibuprofen one. This kind
of result has been previously described and it is characteristic of ibu
profen adopting a liquid like behaviour inside the silica mesopores
[22]. The most important change is a shift of the carbonyl signal from
177.4 ppm for ibuprofen in ethanol solution to 179.4 ppm for the 20:80
to 35:65 samples. This shift is probably related to a change in the hy
drogen bond network of the carbonyl group (dimer formation, inter
action with ethanol OH groups.,.). However contrary to the ethanol
solution, few weak 13C CP/MAS signals for the most rigid parts of the
ibuprofen molecules could be detected for the 20:80 to 35:65 samples
evidencing some mobility restriction of ibuprofen in the pores. This
hypothesis is reasonable, as the molecule is approximatively 11.5 Å
long in a 2.9 nm diameter pore and ibuprofen mobility can be reduced
due to steric hindrance. For the 40:60 sample, 13C CP/MAS shows a new
set of intense ibuprofen resonances that correspond to crystallized
ibuprofen molecules.
This result is reliable with XRD for which the crystalline phase is
ﬁrst detected for the 40:60 sample. These crystalline phase signals have
weak intensities in the 13C MAS spectrum. The methyl 3 13C MAS signal
Fig. 9. 13C MAS spectra (relaxation delay of 5 s) of ibuprofen dissolved in ethanol, raw ibuprofen and spray-dried samples with diﬀerent ibuprofen/silica ratios; *:
Ethanol.
Fig. 10. 13C CP MAS spectra (contact time of 2m s) of ibuprofen dissolved in ethanol, raw ibuprofen and spray-dried samples with diﬀerent ibuprofen/silica ratios.
4. Conclusion
An innovative nano co spray drying process has been used for the
ﬁrst time to load mesoporous silica nanoparticles (diameter of 300 nm/
pore size of 2.9 nm) with ibuprofen molecules. Multi scale advanced
characterization techniques provided key results on the location and
the state of ibuprofen depending on the ibuprofen/silica ratio in the
initial suspension:
Micrometric agglomerates obtained by spray drying go from sphe
rical hollow spheres at low ibu:silica weight ratios, to irregular
Theoretical ibu:Si (w/w) ratio 20:80 25:75 40:60 50:50
Ibu:Si (w/w) ratio calculated by TGA 14:86 23:77 30:70 35:65
Internal Liquid-like (%)a 14 23 28 23
Amorphous (%)b n.d. n.d. n.d. 5
External Crystalline (%)b 2 7
« Internal ibu »:Si molar ratio 4:96 8:92 10:90 11:89
Pore loading rate 21% 42% 53% 58%
n.d.: Not detected.
a Measured from area integration of methyl 3 resonance in13C MAS experi-
ments.
b Determined from signal deconvolution of carbonyl 1 resonance in13C CP/
MAS experiments both included in solid ibuprofen.
can be used to measure the diﬀerent phase population: i) it shows 
diﬀerent chemical shift for the solid and liquid like phase at 14.7 and 
17.5 ppm, respectively (Appendix A Fig. S9); ii) the 13C T1 of this group 
is similar in both phases with a short value of 1.0 s. For the 40:60 
sample, the crystallized ibuprofen phase represents 7 ± 2% of the total 
ibuprofen. For the 50:50 and 80:20 samples, a strong increase of the 
relative proportion of the solid ibuprofen phase is observed in the 13C 
CP/MAS and MAS experiments. Moreover, the shapes of the carbonyl 
and aromatic carbon resonances are complex and result from the su 
perposition of sharp resonances (crystallized form) and broad ones 
(amorphous form). The relative proportion of the amorphous phase 
increases for the 80:20 sample compared to the 50:50 one with crys 
tallized/amorphous ratios of 40/60 and 55/45, respectively (de 
termined by signal deconvolution). 13C MAS experiments also evidence 
a broadening of the liquid like phase resonances for the 40:60 to 80:20 
sample. It could be the sign of a partial structuration of ibuprofen 
molecules conﬁned into the mesopores when the ibuprofen amount is 
increased. This hypothesis is conﬁrmed by the 13C INEPT MAS experi 
ments (Appendix A Fig. S10) that allow detection of very mobile ibu 
profen molecules. The 13C INEPT signal intensities are strong for 20:80 
and 25:75 samples. These signals then decrease continuously from 
35:65 to 80:20 samples indicating a notable diminution of the mobility 
of ibuprofen into the mesopores with an increase of ibuprofen amount 
inside them. It is consistent with the previous hypothesis (from SAXS 
and N2 adsorption results, see Fig. 2 d,e,f), in which the amorphous 
phase results of ibuprofen densiﬁcation inside the pores. This amor 
phous phase is the most dense phase that can be found in the pores, 
because these don't reach the required size to allow ibuprofen crystals 
formation. As the ibuprofen concentration is increased in the stock 
suspension, both solvated and physisorbed ibuprofen amounts are in 
creased due to the thermodynamic equilibrium. However, this “amor 
phous condensed phase” has never been observed for MSN loaded by 
impregnation. It means that the evaporation process should play a key 
role in the densiﬁcation of ibuprofen into the pores. Then, for ratios 
higher than 40:60, the chronological steps of ibuprofen evolution could 
be the following (Fig. 2): i) stock solution with free and physisorbed 
(liquid like) ibuprofen, ii) spray drying process increasing the amount 
of “internal ibuprofen” by densiﬁcation (solid amorphous phase) due to 
the diﬀusion of previously “free” ibuprofen into the pores induced by 
the ethanol evaporation, iii) crystallisation of remaining free ibuprofen 
still during spray drying. Consequently, for these samples, both internal 
(densiﬁcation from liquid like to amorphous) and “external” (crystal 
lized) forms are enhanced. The deconvolution of corresponding solid 
state NMR peaks allows determining the proportion of liquid like, 
amorphous and crystalline ibuprofen. By combining these results 
(Table 5) with TGA results (silica/total ibuprofen ratio), it is possible to 
calculate the ratio (Rexp) between “internal” ibuprofen (liquid 
like + amorphous) and silica. Assuming a total and dense loading of the
Table 5
Quantiﬁcation of diﬀerent ibuprofen states by NMR spectroscopy. The pore 
loading rate has been calculated combining NMR, TGA and N2 adsorption re-
sults.
porous network, the ibuprofen/silica ratio (Rtheo) can also be approxi 
mated: the amount of ibuprofen is obtained by considering the pore 
volume of MSN Vp = 0.754 cm3 g−1 and the density of condensed 
crystalline ibuprofen i.e. d = 1.076 g cm−3 [25]. Finally, the pore 
loading rate is estimated by the comparison (Rexp/Rtheo) of these ratios 
(Table 5). It can be observed that the pore loading rate quickly in 
creases from R = 20:80 to R = 40:60. This increase slows down after 
the apparition of solid ibuprofen phases (amorphous and crystalline), 
with a pore loading rate barely to 60% for R = 50:50. This good loading 
rate is close to those described in the literature [16] for impregnation 
(approximatively corresponding to 30 wt% of ibuprofen) but in this 
case with a continuous, robust and faster process. This loading rate 
could be improved (and the amount of crystallized/external ibuprofen 
decreased) by optimizing some of the parameters of the spray drying 
process such as the drying temperature or the concentration of the in 
itial suspension.
1H MAS NMR gives additional information on the ibuprofen/silica 
system. Due to strong 1H 1H dipolar couplings, the 1H signal of solid 
ibuprofen are very broad as usual (Fig. 11). On contrary, the liquid like 
phase shows sharp signals due to strong reduction of dipolar couplings 
associated with fast motions. As for 13C MAS results, 1H MAS NMR of 
samples 20:80 to 40:60 are very similar to the dissolved ibuprofen one. 
Continuous broadening of 1H resonances with increase of ibuprofen 
amount is also observed especially for ratio above 35:65 (notably for 
hydrogen 10). It conﬁrms the reduction of the mobility of ibuprofen 
located into the mesopores when the ibuprofen concentration increase. 
The spray dried silica (100:0) shows mostly a broad signal at 4.9 ppm 
corresponding to hydrogens of SiOH groups in fast exchange with hy 
drogens of physisorbed water molecules. This signal continuously shift 
from 5.2 to 6.5 ppm for 20:80 to 50:50 samples. This shift is probably 
the result of several contributions: i) removing water molecules evi 
dence by TGA analyses, ii) increase contribution of ibuprofen OH 
groups detected at 6.2 ppm in ethanol solution, iii) possible formation 
of hydrogen bonds between SiOH and ibuprofen carboxylic group and 
iv) ring current eﬀect of the ibuprofen aromatic cycle. Anyway, this OH 
signal shift conﬁrms the increase concentration of ibuprofen inside the 
mesopores. Note that the OH signal goes back to 6.4 ppm for 80:20 
sample possibly due to a weak water contamination.
No information about ibuprofen/silica interaction could be obtained 
by 1H/29Si HETCOR experiments where only correlations between OH 
groups and silicon atoms are observed (not shown). 1H NOESY ex 
periment (notably performed for the 35:65 sample) on contrary, shows 
cross peaks between OH hydrogens and diﬀerent ibuprofen hydrogens 
associated to spatial proximities (SI Fig. S11). As NOE cross peaks of 
similar intensities are observed with methyl groups on each side of the 
molecules (methyls 3, 12 and 13) but also with the aromatic hydrogens 
(5 8), it can be concluded that there is no preferential orientation of the 
ibuprofen molecules into the mesopores. In fact, only the less accessible 
alkane groups 10 and 11 do not show NOE cross peaks with the OH 
hydrogens. This is in line with the important mobility of ibuprofen in 
the pores. Indeed, in the case where strong interaction between ibu 
profen and silica may have been present (through hydrogen bond for 
example), the ibuprofen mobility should have been weaker and speciﬁc 
NOE correlations should have been observed.
shapes and larger sizes at higher ratios.
The drug loading of the MSN is the result of two consecutive stages
of pore ﬁlling: ibuprofen physisorption in the initial suspension and
then diﬀusion of the ibuprofen molecules into the pores driven by
the solvent evaporation during the spray drying process.
Up to 35:65 ibu:silica weight ratio, ibuprofen is encapsulated into
the mesopores and adopts a liquid like behaviour. The amount of
encapsulated ibuprofen continuously increases with the initial ibu
profen concentration.
At 40:60 ratio, a crystalline ibuprofen phase appears out of the
porous network and its amount increases for higher ratios. A second
“solid” phase is detected at the 50:50 ibu:silica ratio and could be
explained by a densiﬁcation of intraporous ibuprofen.
Beyond mechanistic and fundamental aspects, the identiﬁcation and
quantiﬁcation of the state of loaded drugs and the ﬁne calculation of
loading rates are of major interest for the industrial transfer of such a
process. This work is the ﬁrst step of the drug loading optimization that
will require an exhaustive study of the eﬀects of other spray drying
parameters.
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